Effects of Hesperidin and Naringenin on Apoptotic Markers in Cisplatin-Induced Nephrotoxicity in Male Wistar Albino Rats

Cisplatin is a widely used platinum-based chemotherapeutic agent for the treatment of several solid malignancies, including testicular, ovarian, bladder, lung, and head-and-neck cancers. However, its clinical use is frequently limited by nephrotoxicity, a major dose-limiting adverse effect affecting approximately 20–30% of patients. This study evaluated the protective effects of hesperidin and naringenin on apoptotic markers in cisplatin-induced nephrotoxicity in male Wistar rats. Thirty-six male Wistar rats were randomly allocated into six groups (n = 6): normal control, cisplatin control, vitamin C reference control (200 mg/kg), hesperidin-treated (200 mg/kg), naringenin-treated (200 mg/kg), and combined hesperidin–naringenin-treated (200 mg/kg each). Treatments were administered orally for 28 days, and nephrotoxicity was induced in Groups B–F by a single intraperitoneal injection of cisplatin (20 mg/kg) on day 28. Renal apoptotic markers, including caspase-3, caspase-9, Bax, and Bcl-2, were assessed. Cisplatin significantly increased renal caspase-3, caspase-9, and Bax levels while significantly reducing Bcl-2 expression compared with the normal control group (p < 0.05), indicating activation of mitochondrial apoptosis. Pretreatment with hesperidin, naringenin, and their combination significantly reduced caspase-3, caspase-9, and Bax expression and restored Bcl-2 levels relative to the cisplatin control group (p < 0.05). The combined treatment produced the most pronounced protective effect. Hesperidin and naringenin effectively attenuated cisplatin-induced nephrotoxicity by suppressing pro-apoptotic markers and enhancing the anti-apoptotic protein Bcl-2 (p < 0.05). Their protective actions, particularly when combined, suggest potential utility as adjunctive agents for mitigating cisplatin-associated renal toxicity through inhibition of mitochondrial-dependent apoptosis. Keywords: Cisplatin; Nephrotoxicity; Hesperidin; Naringenin; Apoptosis; Oxidative Stress.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-09-15
DOI
https://doi.org/10.5281/zenodo.22762595
Primary Topic
Chemotherapy-induced organ toxicity mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Effects of Hesperidin and Naringenin on Apoptotic Markers in Cisplatin-Induced Nephrotoxicity in Male Wistar Albino Rats

C.E. Offor, U. C. Okorie, C.O. Ogbu, E.C. Duruiheoma et al.
Zenodo (CERN European Organization for Nuclear Research)
Chemotherapy-induced organ toxicity mitigation
article

Effects of Hesperidin and Naringenin on Apoptotic Markers in Cisplatin-Induced Nephrotoxicity in Male Wistar Albino Rats

C.E. Offor, U. C. Okorie, C.O. Ogbu, E.C. Duruiheoma, E Okechukwu, P.M. Aja, R.O Duruiheoma
article en

Abstract

Cisplatin is a widely used platinum-based chemotherapeutic agent for the treatment of several solid malignancies, including testicular, ovarian, bladder, lung, and head-and-neck cancers. However, its clinical use is frequently limited by nephrotoxicity, a major dose-limiting adverse effect affecting approximately 20–30% of patients. This study evaluated the protective effects of hesperidin and naringenin on apoptotic markers in cisplatin-induced nephrotoxicity in male Wistar rats. Thirty-six male Wistar rats were randomly allocated into six groups (n = 6): normal control, cisplatin control, vitamin C reference control (200 mg/kg), hesperidin-treated (200 mg/kg), naringenin-treated (200 mg/kg), and combined hesperidin–naringenin-treated (200 mg/kg each). Treatments were administered orally for 28 days, and nephrotoxicity was induced in Groups B–F by a single intraperitoneal injection of cisplatin (20 mg/kg) on day 28. Renal apoptotic markers, including caspase-3, caspase-9, Bax, and Bcl-2, were assessed. Cisplatin significantly increased renal caspase-3, caspase-9, and Bax levels while significantly reducing Bcl-2 expression compared with the normal control group (p < 0.05), indicating activation of mitochondrial apoptosis. Pretreatment with hesperidin, naringenin, and their combination significantly reduced caspase-3, caspase-9, and Bax expression and restored Bcl-2 levels relative to the cisplatin control group (p < 0.05). The combined treatment produced the most pronounced protective effect. Hesperidin and naringenin effectively attenuated cisplatin-induced nephrotoxicity by suppressing pro-apoptotic markers and enhancing the anti-apoptotic protein Bcl-2 (p < 0.05). Their protective actions, particularly when combined, suggest potential utility as adjunctive agents for mitigating cisplatin-associated renal toxicity through inhibition of mitochondrial-dependent apoptosis. Keywords: Cisplatin; Nephrotoxicity; Hesperidin; Naringenin; Apoptosis; Oxidative Stress.

Zenodo (CERN European Organization for Nuclear Research)
Funai Electric (Japan) (JP), Benue State University (NG), Ebonyi State University (NG)
Good health and well-being
Openalex Percentile: Top 11%
Chemotherapy-induced organ toxicity mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.